ESC 365 - Welcome and introduction - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

ESC Premium Access

Welcome and introduction - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

Session: Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice (EBAC Accredited)

Topic: Thrombosis and platelets

Speaker: Professor P. Steg (Paris, FR)

Sponsored by AstraZeneca

Event: ESC CONGRESS 2017

Congress Session

About the speaker

Professor Philippe Gabriel Steg

Hospital Bichat-Claude Bernard, Paris (France)

47 presentations

2 followers

3 more presentations in this session

Extending the duration of dual antiplatelet therapy: a clinical case study.

Speaker: Doctor D. Angiolillo (Jacksonville, US)

Open questions - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

Speaker: Professor P. Steg (Paris, FR) Doctor D. Angiolillo (Jacksonville, US)

Session close - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

Speaker: Professor P. Steg (Paris, FR)

Access the full session

Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice (EBAC Accredited)

Speakers: Professor P. Steg, Doctor D. Angiolillo, Professor P. Steg, Doctor D. Angiolillo, Professor P. Steg

About the event

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

Congress

This platform is supported by